BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 22832160)

  • 1. Transcriptional activation by Oct4 is sufficient for the maintenance and induction of pluripotency.
    Hammachi F; Morrison GM; Sharov AA; Livigni A; Narayan S; Papapetrou EP; O'Malley J; Kaji K; Ko MS; Ptashne M; Brickman JM
    Cell Rep; 2012 Feb; 1(2):99-109. PubMed ID: 22832160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OCT4 supports extended LIF-independent self-renewal and maintenance of transcriptional and epigenetic networks in embryonic stem cells.
    He R; Xhabija B; Al-Qanber B; Kidder BL
    Sci Rep; 2017 Nov; 7(1):16360. PubMed ID: 29180818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Itch, an E3 ligase of Oct4, is required for embryonic stem cell self-renewal and pluripotency induction.
    Liao B; Zhong X; Xu H; Xiao F; Fang Z; Gu J; Chen Y; Zhao Y; Jin Y
    J Cell Physiol; 2013 Jul; 228(7):1443-51. PubMed ID: 23255053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethyl-p-methoxycinnamate enhances oct4 expression and reinforces pluripotency through the NF-κB signaling pathway.
    Ai H; Qin H; Li J; Niu C; Song Z; Bao Y; Sun L; Zheng L; Li Y
    Biochem Pharmacol; 2020 Jul; 177():113984. PubMed ID: 32311348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption of OCT4 Ubiquitination Increases OCT4 Protein Stability and ASH2L-B-Mediated H3K4 Methylation Promoting Pluripotency Acquisition.
    Li S; Xiao F; Zhang J; Sun X; Wang H; Zeng Y; Hu J; Tang F; Gu J; Zhao Y; Jin Y; Liao B
    Stem Cell Reports; 2018 Oct; 11(4):973-987. PubMed ID: 30269953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment of leukemia inhibitory factor (LIF)-independent iPS cells with potentiated Oct4.
    Hirai H; Firpo M; Kikyo N
    Stem Cell Res; 2015 Nov; 15(3):469-480. PubMed ID: 26413786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamical reorganization of the pluripotency transcription factors Oct4 and Sox2 during early differentiation of embryonic stem cells.
    Verneri P; Vazquez Echegaray C; Oses C; Stortz M; Guberman A; Levi V
    Sci Rep; 2020 Mar; 10(1):5195. PubMed ID: 32251342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A conserved Oct4/POUV-dependent network links adhesion and migration to progenitor maintenance.
    Livigni A; Peradziryi H; Sharov AA; Chia G; Hammachi F; Migueles RP; Sukparangsi W; Pernagallo S; Bradley M; Nichols J; Ko MSH; Brickman JM
    Curr Biol; 2013 Nov; 23(22):2233-2244. PubMed ID: 24210613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oct4 and LIF/Stat3 additively induce Krüppel factors to sustain embryonic stem cell self-renewal.
    Hall J; Guo G; Wray J; Eyres I; Nichols J; Grotewold L; Morfopoulou S; Humphreys P; Mansfield W; Walker R; Tomlinson S; Smith A
    Cell Stem Cell; 2009 Dec; 5(6):597-609. PubMed ID: 19951688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The death-inducer obliterator 1 (Dido1) gene regulates embryonic stem cell self-renewal.
    Liu Y; Kim H; Liang J; Lu W; Ouyang B; Liu D; Songyang Z
    J Biol Chem; 2014 Feb; 289(8):4778-86. PubMed ID: 24347171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Oct4 in maintaining and regaining stem cell pluripotency.
    Shi G; Jin Y
    Stem Cell Res Ther; 2010 Dec; 1(5):39. PubMed ID: 21156086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Oct4-activating compounds that enhance reprogramming efficiency.
    Li W; Tian E; Chen ZX; Sun G; Ye P; Yang S; Lu D; Xie J; Ho TV; Tsark WM; Wang C; Horne DA; Riggs AD; Yip ML; Shi Y
    Proc Natl Acad Sci U S A; 2012 Dec; 109(51):20853-8. PubMed ID: 23213213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trib2 regulates the pluripotency of embryonic stem cells and enhances reprogramming efficiency.
    Do EK; Park JK; Cheon HC; Kwon YW; Heo SC; Choi EJ; Seo JK; Jang IH; Lee SC; Kim JH
    Exp Mol Med; 2017 Nov; 49(11):e401. PubMed ID: 29170476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Amniocytes Are Receptive to Chemically Induced Reprogramming to Pluripotency.
    Hawkins KE; Moschidou D; Faccenda D; Wruck W; Martin-Trujillo A; Hau KL; Ranzoni AM; Sanchez-Freire V; Tommasini F; Eaton S; De Coppi P; Monk D; Campanella M; Thrasher AJ; Adjaye J; Guillot PV
    Mol Ther; 2017 Feb; 25(2):427-442. PubMed ID: 28153093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Oct4 homologue PouV and Nanog regulate pluripotency in chicken embryonic stem cells.
    Lavial F; Acloque H; Bertocchini F; Macleod DJ; Boast S; Bachelard E; Montillet G; Thenot S; Sang HM; Stern CD; Samarut J; Pain B
    Development; 2007 Oct; 134(19):3549-63. PubMed ID: 17827181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel SALL4/OCT4 transcriptional feedback network for pluripotency of embryonic stem cells.
    Yang J; Gao C; Chai L; Ma Y
    PLoS One; 2010 May; 5(5):e10766. PubMed ID: 20505821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced OCT4 transcriptional activity substitutes for exogenous SOX2 in cellular reprogramming.
    Marthaler AG; Adachi K; Tiemann U; Wu G; Sabour D; Velychko S; Kleiter I; Schöler HR; Tapia N
    Sci Rep; 2016 Jan; 6():19415. PubMed ID: 26762895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A defined Oct4 level governs cell state transitions of pluripotency entry and differentiation into all embryonic lineages.
    Radzisheuskaya A; Chia Gle B; dos Santos RL; Theunissen TW; Castro LF; Nichols J; Silva JC
    Nat Cell Biol; 2013 Jun; 15(6):579-90. PubMed ID: 23629142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual roles of Oct4 in the maintenance of mouse P19 embryonal carcinoma cells: as negative regulator of Wnt/β-catenin signaling and competence provider for Brachyury induction.
    Marikawa Y; Tamashiro DA; Fujita TC; Alarcon VB
    Stem Cells Dev; 2011 Apr; 20(4):621-33. PubMed ID: 21083502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic tool for fate mapping of Oct4 (Pou5f1)-expressing cells and their progeny past the pluripotency stage.
    Kuzmin AA; Ermakova VV; Sinenko SA; Ponomartsev SV; Starkova TY; Skvortsova EV; Cherepanova O; Tomilin AN
    Stem Cell Res Ther; 2019 Dec; 10(1):391. PubMed ID: 31843009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.